yttrium Y 90 DOTA monoclonal antibody HuAFP31

Known as: Yttrium Y-90 Tacatuzumab Tetraxetan, Yttrium Y 90 Tacatuzumab Tetraxetan, Y90 DOTA MOAB HuAFP31 
A radioimmunoconjugate comprised of the humanized monoclonal antibody tacatuzumab, directed against alpha fetoprotein, that is conjugated to the… (More)
National Institutes of Health

Topic mentions per year

Topic mentions per year

2009-2015
012320092015

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2016
Review
2016
Intra-arterial radionuclide therapies serve essentially as internal radiation treatment options for both primary and metastatic… (More)
  • table 1
  • figure 1
  • figure 2
  • table 2
  • figure 3
Is this relevant?
2015
2015
BACKGROUND For patients with metastatic pancreatic adenocarcinoma, there are no approved or established treatments beyond the 2nd… (More)
Is this relevant?
Review
2015
Review
2015
The commercial pipeline of recombinant antibody therapeutics is robust and dynamic. As of early December 2014, a total of 6 such… (More)
Is this relevant?
Review
2014
Review
2014
PURPOSE The purpose of this presentation is to discuss the radiation safety and dosimetric technique used for the therapeutic… (More)
Is this relevant?
Review
2014
Review
2014
The commercial pipeline of monoclonal antibodies is highly dynamic, with a multitude of transitions occurring during the year as… (More)
Is this relevant?
2013
2013
The biodistribution of the anti-CD37 radioimmunoconjugate (177)Lu-tetraxetan-tetulomab ((177)Lu-DOTA-HH1) was evaluated… (More)
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
Is this relevant?
2011
2011
Purpose: Humanized antibody hPAM4 specifically binds a mucin glycoprotein expressed in pancreatic adenocarcinomas. This phase I… (More)
  • table 1
  • table 2
  • figure 1
  • table 3
  • table 4
Is this relevant?
2011
2011
Purpose: Humanized antibody hPAM4 specifically binds a mucin glycoprotein expressed in pancreatic adenocarcinomas. This phase I… (More)
  • table 1
  • table 2
  • figure 1
  • table 3
  • table 4
Is this relevant?
2009
2009
UNLABELLED Pancreatic cancer is a silent disease that most commonly presents in an already metastatic form. Current treatment… (More)
Is this relevant?
2009
2009
The use of selective internal radiation therapy for treatment of hepatocellular carcinoma and liver metastases using Y-90 labeled… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?